# FDA recall D-0209-2018

> **Prinston Pharmaceutical Inc** · Class II · drug recall initiated 2017-11-29.

## Product

Valsartan Tablets, USP, 160 mg, 90-count bottles, Rx Only, Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd, Xunqiao, Linhai, Zhejiang 317024, China; Distributed by: Solco Healthcare US, LLC, Cranbury, NJ 08512, USA; NDC 43547-369-09.

## Reason for recall

Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-0209-2018
- **Recalling firm:** Prinston Pharmaceutical Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-11-29
- **Report date:** 2018-01-17
- **Termination date:** 2019-08-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Cranbury, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0209-2018

## Citation

> AI Analytics. FDA recall D-0209-2018. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0209-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*